Interferon-alpha in the treatment of multiple myeloma

Keyphrases

• Allogeneic Transplantation 14%
• Antiproliferative Activity 14%
• Biological Response Modifiers 14%
• Bortezomib 14%
• Chemotherapy Agents 14%
• Chemotherapy Regimen 14%
• Clinical Practice 14%
• Clinical Trials 14%
• Coinduction 28%
• Complete Remission 14%
• Conventional Chemotherapy 14%
• Future Role 14%
• Hematological Malignancies 14%
• History Book 14%
• Immunomodulating 14%
• Interferon-α (IFN-α) 100%
• Lenalidomide 14%
• Maintenance Therapy 28%
• Meta-analysis 14%
• Multiple Myeloma 100%
• Myeloma 28%
• New Drugs 14%
• Plateau Phase 14%
• Soluble Protein 14%
• Thalidomide 14%
• Virus 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Alpha Interferon 100%
• Biological Response Modifier 16%
• Bortezomib 16%
• Chemotherapy 33%
• Chemotherapy Agent 16%
• Clinical Trial 16%
• Hematologic Malignancy 16%
• Interferon 100%
• Lenalidomide 16%
• Multiple Myeloma 100%
• Myeloma 50%
• Protein 16%
• Remission 16%
• Thalidomide 16%

Medicine and Dentistry

• Anesthesia Induction 66%
• Bortezomib 16%
• Chemotherapy Agent 16%
• Myeloma 50%